US Patent Issued to Denali Therapeutics on March 4 for "Anti-TREM2 antibodies and methods of use thereof" (California Inventors)

ALEXANDRIA, Va., March 5 -- United States Patent no. 12,240,902, issued on March 4, was assigned to Denali Therapeutics Inc. (South San Francisco, Calif.).

"Anti-TREM2 antibodies and methods of use thereof" was invented by Mark S. Dennis (South San Francisco, Calif.), Sherie Duncan (South San Francisco, Calif.), Kathleen Lisaingo (South San Francisco, Calif.), Kathryn M. Monroe (South San Francisco, Calif.), Joshua I. Park (South San Francisco, Calif.), Rachel Prorok (South San Francisco, Calif.), Ju Shi (South San Francisco, Calif.), Ankita Srivastava (South San Francisco, Calif.), Bettina Van Lengerich (South San Francisco, Calif.) and Riley Walsh (South San Francisco, Calif.).

According to the abstract* released by the U.S. Patent & Tr...